Megan Coder, PharmD, MBA, is vice president, product & policy, at the Digital Medicine Society (DiMe), where she leads a portfolio focused on digital health technology policy, product assessment, and real-world impact. Prior to her time with DiMe, Coder was the executive director and founder of the Digital Therapeutics Alliance (DTA). Through thought leadership, international standard development, and global policy collaborations, she led industry efforts to establish digital therapeutics (DTx) as a new category of medicine. Trained as a pharmacist, she graduated from the University of Wisconsin—Madison and completed an executive residency in association management & leadership with the American Pharmacists Association.